Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioArctic receives patent in Japan for new antibodies targeting Alzheimer’s disease

Stockholm, May 11, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the Japanese Patent Office (JPO) has allowed the company’s Japanese patent application 2017-083057 for novel antibodies that could be developed into a treatment for Alzheimer’s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aβ) and are linked to the company’s project AD1503. BioArctic received a patent in Europe based on the same antibodies in January 2021.The allowed patent application focuses on novel antibodies which target pE3-Aβ, a specific truncated form of

Lagercrantz Year-End Report 2020/21

Fourth quarter (1 January – 31 March 2021) · Net revenue totalled MSEK 1,118 (1,112). · Operating profit (EBITA) increased to MSEK 192 (152), equivalent to an operating margin of 17.2 percent (13.7). · Profit after financial items increased by 32 percent to MSEK 166 (126). · Profit after taxes increased to MSEK 126 (101). · During the quarter, five businesses were acquired (VP Metall AS, Hovicon International B.V., Oy Esari Ab, Proagria Miljø A/S and Vihab AB) with a total business volume of approx.  MSEK 200 on an annual basis. · In March 2021, a clarified strategic

Strong revenue momentum and business model scalability

Financial highlights first quarter                                                                                                                                                         · Net sales increased by 33.1 percent to EUR 28.1m (21.1). Organic growth excluding currency effects was 40.2 percent (21.4). · Gross profit amounted to EUR 14.5m (11.4) with a gross margin of 51.5 percent (53.7). · Adjusted EBITDA amounted to EUR 5.5m (3.2) with an adjusted EBITDA margin of 19.7 percent (15.0). · Adjusted basic and diluted earnings per share amounted to EUR 0.04 (0.01).

Metso Outotec completes merger clearance process in India

Metso Outotec Corporation’s press release on May 11, 2021, at 09:00 a.m. EESTThe combination of Metso Minerals and Outotec was conditionally approved by the Competition Commission of India (CCI) in June 2020, subject to the transfer of legacy Metso’s straight grate iron ore pelletizing capital equipment business by Metso Outotec in India to a suitable buyer through a technology licensing arrangement. This condition has now been satisfied, as Metso Outotec has, with the approval of the CCI, licensed the relevant technology to Primetals Technologies, a joint venture of Mitsubishi Heavy

Estonians and Russians want plenty of light and open spaces, whereas Czechs and Lithuanians value a garden - the range of living solutions is extensive around Europe

YIT CORPORATION Press release May 11, 2021, at 09:00 a.m.According to the Sustainable urban environments barometer, new apartments are little more sought-after than old apartments New and old apartments are a polarising question, as people have different hopes and dreams. As there are many forms of ideal housing, the range of living solutions is extensive in Finland and in other YIT countries. According to the Sustainable urban environments barometer*, commissioned by YIT in the autumn of 2020, new apartments are only a little more sought-after than old apartments; among respondents,

SAS starts new route from Luleå to London

SAS will introduce a seasonal route with non-stop flights from Luleå to London, Heathrow, starting December 17, 2021, to March 21, 2022. Flights will operate twice a week, on Mondays and Fridays, and it will be the only direct link between Luleå and the UK.Luleå and the Swedish Lapland region attracts travelers with many high-end hotels and activities suited for the English market. The timetable also works well for weekend trips to London from Luleå and will shorten the distance from the North of Sweden to one of the world’s great capitals and business regions.“We are delighted to be able

Orthex Q1: Excellent growth in all product categories and market areas

Orthex Corporation, Stock exchange release, May 11, 2021 at 9.00 a.m. EEST This release is a summary of Orthex Corporation’s Interim Report January–March 2021. The complete report is attached to this release as a pdf-file. It is also available on Orthex’s website at https://investors.orthexgroup.com/.January–March 2021 in Brief · Invoiced sales increased by 33.5% and was EUR 22.4 million (16.8) · Net sales increased by 32.4% to EUR 21.6 million (16.3) · Adjusted EBITDA was EUR 4.3 million (3.0) (adjusted for IPO related costs EUR 1.3 million) · EBITA was EUR 2.0 million (1.

Moberg Pharma AB Interim report January - March 2021

REGISTRATION PREPARATIONS FULLY UNDERWAYFIRST QUARTER (JAN-MAR 2021) · EBITDA SEK -5.4 million (-3.6) * · Operating profit (EBIT) SEK -6.1 million (-4.2) * · Profit after tax SEK -5.0 million (-3.4) * · Total profit SEK 18.6 million (-3.4) · Diluted earnings per share SEK 0.46 (-0.18) * · Cash and cash equivalents amounted to SEK 133.6 million (51.6) · Cash and cash equivalents SEK 142 million adjusted for effects of OncoZenge divestment (reversed in Q2) * All comparative figures refer to continuing operations  SIGNIFICANT EVENTS IN THE FIRST QUARTER  · A

SciBase launches Non-melanoma Skin cancer indication for Nevisense

STOCKHOLM, SWEDEN, — May 11, 2021 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the launch of the new Non-Melanoma Skin Cancer (NMSC) clinical application following the completion of their MDR certification process.SciBase’s strategy is to leverage the Nevisense technology platform to launch additional clinical applications and products. The first clinical application or indication to be added is NMSC, initially for Nevisense 3.0. There are two types of skin cancer: melanoma and non-melanoma

S&P Global Ratings revised Metso Outotec’s outlook to stable

Metso Outotec Corporation’s press release on May 11, 2021, at 09:00 a.m. EESTS&P Global Ratings has today revised Metso Outotec’s outlook from negative to stable. The rating is BBB-, stable outlook. Please see more information on S&P Global Rating’s report www.mogroup.com/corporate/investors/debt-investors. Moody’s confirmed Baa2, stable outlook rating to Metso Outotec in April 2021. Please see more information on Moody’s report www.mogroup.com/corporate/investors/debt-investors. Metso Outotec’s target is to maintain an investment-grade credit rating. Further information, please

Interim report January - March 2021

First quarter 2021 · Revenues amounted to MSEK 364.5 (MSEK 400.4), a decrease by 9% compared to the same period last year. · Operating profit amounted to MSEK 92.5 (MSEK 165.9), a decrease by 44 %. · Profit after financial items amounted to MSEK 91.6 (MSEK 164.7), and profit after tax amounted to MSEK 76.7 (MSEK 128.0). · Cash flow from operating activities amounted to MSEK 145.7 (MSEK 247.7), and cash flow from investing activities amounted to MSEK -189.2 (MSEK -166.4). · By the end of the period cash amounted to MSEK 717.6 (MSEK 625.1).  · Earnings per share amounted

Starbreeze AB (publ) Interim report Q1 2021

First quarter 2021 •     Net sales amounted to SEK 27.9 million (22.0). PAYDAY accounted for SEK 26.9 million (21.7). •     EBITDA amounted to SEK 22.6 million (16.9). •     Amortization, depreciation and impairments amounted to SEK 14.5 million (10.4). •     Profit before tax was SEK -4.2 million (-97.3). •     Basic and diluted earnings per share were SEK -0.01 (-0.28). •     Cash and cash equivalents amounted to SEK 148.5 million (107.9). •     Starbreeze has entered into a global co-publishing agreement with the leading European publishing partner Koch Media for

Navamedic ASA: Q1 2021 financial

Oslo, 11 May 2021 – Navamedic ASA (OSE: NAVA) grew revenues by 5.4% in the first quarter of 2021 compared to the same quarter last year. The company reported revenues of NOK 58.6 million in the first quarter of 2021 with an EBITDA of NOK 2.6 million, driven by both new products, underlying growth and an improved revenue mix. The company reiterates its mid- to long-term ambition of building a NOK 500 million company.“In the first quarter of 2021, we continued to deliver growth in our underlying portfolio. The rapid growth of specialty pharma product Mysimba and the consumer health products

Updated Definitive Feasibility Study for Engebø confirms reduction of initial investment of USD 93 million and improved environmental performance

Nordic Mining ASA (“Nordic Mining”) has completed the Updated Definitive Feasibility study (“UDFS”) for the Engebø Rutile and Garnet project (“the Project”). The UDFS is an update of the DFS which was completed in January 2020. As a consequence of the COVID-19 pandemic and uncertainties related to the markets for rutile and garnet, and the opportunities for securing project financing, Nordic Mining decided in spring 2020 to undertake a Value Engineering review to make the Project more resilient.The updated study documents Engebø as a sustainable and economically robust mineral project

Stora Enso and Pulpex partner to produce fiber-based bottles on industrial scale

STORA ENSO OYJ PRESS RELEASE 11 May 2021 at 9.00 EESTStora Enso and packaging technology company Pulpex join forces to industrialize the production of eco-friendly paper bottles and containers made from wood fiber pulp. These renewable products will offer an alternative to PET plastics and glass. The exclusive partnership leverages Stora Enso’s formed fiber technologies and ability to convert end-products at an industrial scale. The joint development agreement is formed exclusively between Stora Enso and Pulpex, a sustainable packaging technology company established by Diageo (makers of

Gala Bingo Review 2022: Bonus, Promotions and Games

If you love your telly-themed bingo games, Gala Bingo might be the one for you.  Gala Bingo  is one of the oldest and most reputable names in UK bingo, so it makes sense that bingo lovers everywhere would sign up! However, with SO many bingo sites to consider today, and so many things to consider - bonuses, promotions, gameplay, game selection etc - Gala Bingo certainly isn’t a shoo-in.  The sharper eyed among you will remember that Gala TV was actually a bingo channel back in the early noughties that gave you the chance to play bingo after

Changes in the Systemair Group Management

Press Release, 11 May 2021 Systemair AB (NASDAQ OMX Stockholm: SYSR) change the Group Management.  Bjørn-Osvald Skandsen, Managing Director for Systemair Norway, will become member of Systemair Group Management starting 12 May 2021. Bjørn-Osvald has many years of experience from the ventilation industry and Systemair. Before re-joining Systemair in March 2018 as Managing Director, he was holding a director’s positions in GK Inneklima - a technical ventilation contractor in Norway. Even earlier in his professional life, he has headed the Systemair group’s technical support

SAS opens new direct route between London Heathrow and Luleå, Swedish Lapland

SAS, Scandinavian Airlines, in conjunction with Swedish Lapland Visitors Board and Luleå Airport, has announced the launch of a new seasonal route for winter 2021-2, which will open a direct connection between London Heathrow and Luleå Airport. The flight will operate on Mondays and Fridays, beginning 17 December 2021 and running until 21 March 2022. It is the only direct flight connection between Swedish Lapland and the United Kingdom and will be operated by modern, fuel-efficient Airbus A320 aircraft in order to minimise climate-affecting emissions. The flight is the culmination of

Quarterly Report January - March 2021 Everysport Media Group AB (publ.)

Acquisitions and strong underlying development creates a basis for continued growthSummary of the first quarter 2021 · Net sales*: 25,5 mkr (20,8 mkr) − which corresponds to an increase of 23% · EBITDA: 1,6 mkr (0,8 mkr) · Profit after tax: 0,5 mkr (−0,4 mkr) · Earnings per share: 0,12 kr (0,01 kr) · Cashflow from operating activities: 1,9 mkr (1,6 mkr) *Including acquisition of Trav- och Galopp Nytt and Hesteportalen, which contruibuted to the increase of revenues with SEK 1,7 million.CEO, Hannes Andersson, comments: The beginning of the year has been very

Nordic Mining ASA (EN Expand:NOM) - Interim report per 31 March 2021

Nordic Mining ASA (EN Expand:NOM) - Interim report per 31 March 2021 Please find enclosed Nordic Mining’s interim report for the first quarter of 2021. The company updates for the first quarter of 2021 and results of the Engebø Updated Feasibility Study will be presented digitally today, Tuesday 11 May 2021 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/landingpage/hegnarmedia/20210511_

Arctic Paper S.A., Q1 2021: Arctic Paper is stronger than in many years

· Q1 consolidated sales revenue was PLN 782,8mn (EUR[1] 172,2mn). · EBITDA Q1 was PLN 72,2mn (EUR[1] 15,9mn). · EBIT Q1 was PLN 43,2mn (EUR[1] 9,5mn) and net profit PLN 32,3mn (EUR[1] 7,1mn). · Continued recovery while the effect of rising pulp prices is delayed due to contractual terms. · High capacity utilization of 94 percent in the paper segment and growth within kraft paper. · New five-year financing agreement totalling PLN 300 million at better terms. · New strategic group R&D function established to accelerate development in packaging. “As pulp prices rise, the

Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti is off to a good start

HIGHLIGHTS Revenue reached DKK 4,273 million in the first quarter of 2021, a decline of 2% in local currencies. EBIT grew 235% compared to the same period in 2020 and reached DKK 882 million. EBIT margin reached 20.6%. EPS grew by 578% in the quarter thereby reaching DKK 3.13. The newest product in the portfolio, Vyepti[®], grew 49% since the fourth quarter of 2020. The brand continues its strong momentum since launch in the second quarter of 2020. Regulatory review is ongoing in 12 markets. Strategic brand performance: · · Revenue of Abilify Maintena[®]:  DKK 584 million

Interim report January – March 2021 Sweco AB (publ)

A stable start to the yearJanuary – March 2021 · Net sales amounted to SEK 5,538 million (5,680) · EBITA amounted to SEK 540 million (630), margin 9.8 per cent (11.1) · EBITA increased 4 per cent year-on-year after adjustment for the substantial negative calendar effect in the quarter · EBIT amounted to SEK 523 million (615), margin 9.4 per cent (10.8) · Net debt improved to SEK 957 million (2,225) · Net debt/EBITDA improved to 0.5 x (1.0) · Profit after tax amounted to SEK 392 million (443), corresponding to SEK 1.10 per share (1.25) Comments from President and

Read original

NOHO PARTNERS PLC INTERIM REPORT 1 JANUARY – 31 MARCH 2021: The first quarter was dominated by strict restrictions and the closure of restaurants – the demand outlook for the summer has improved after the difficult spring

NoHo Partners Plc INTERIM REPORT 11 May 2021 at 8:15 a.m. NOHO PARTNERS PLC INTERIM REPORT 1 JANUARY – 31 MARCH 2021 The first quarter was dominated by strict restrictions and the closure of restaurants – the demand outlook for the summer has improved after the difficult springNoHo Partners’ business was subject to strict restrictions in the first quarter of 2021 and, following an order issued by the Finnish Government, restaurant operations in Finland were shut down starting from 8 March 2021 in the regions where the COVID-19 pandemic was in the acceleration or community

There are no items matching the current filter
There are no more items matching the current filter
Back to top